Manuscripts
- Meta-Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure (open-access)
- Automated Poisson regression exposure–response analysis for binary outcomes with PoissonERM (open-access)
- Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis (open-access)
- Tumor growth inhibition modeling to support the starting dose for dacomitinib (Open Access)
